CME/CE

Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...

Faculty: David Rubin, MD Faculty: Kimberly D. Orleck, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. T...

Faculty: David Rubin, MD Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets....

Faculty: Kimberly D. Orleck, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic...

Faculty: Jennifer Geremia, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic t...

Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...

Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Diana Castro and Jonathan Strober discuss treatment strategies for generalized myasthenia gravis (gMG), focusing on pediatric and adolescent care. They review traditional therapies and newer agents, such as FcRn and complement inhibitors, highlighting the role of antibody status and considerations for thymectomy. The conversation also ad...

Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD This discussion between Drs. Diana Castro and Jonathan Strober focuses on the clinical utility of patient stratification and antibody profiling in generalized myasthenia gravis (gMG). The conversation addresses how age of onset, antibody status (acetylcholine receptor, MuSK, LRP4), and comorbidities can influence diagnosis and management plan...

Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Jonathan Strober and Diana Castro examine the diagnostic approach to generalized myasthenia gravis (gMG), with a focus on age-related differences in clinical presentation. They describe early signs in pediatric patients—such as ptosis and impaired extraocular movements—and contrast these with the fluctuating fatigue, bulbar involvement,...

Faculty: Erin Bohula, MD, DPhil Faculty: Lawrence Leiter This program explores evolving strategies for low-density lipoprotein cholesterol (LDL-C) management in patients at high cardiovascular (CV) risk who have not yet experienced a myocardial infarction or stroke. Drs. Bohula and Leiter discuss unmet needs, shifting LDL-C targets, and emerging treatment strategies, including PCSK9 inhibitors and...

Faculty: Erin Bohula, MD, DPhil Faculty: Lawrence Leiter This program explores evolving strategies for low-density lipoprotein cholesterol (LDL-C) management in patients at high cardiovascular (CV) risk who have not yet experienced a myocardial infarction or stroke. Drs. Bohula and Leiter discuss unmet needs, shifting LDL-C targets, and emerging treatment strategies, including PCSK9 inhibitors and...

Host: Andrew S. Bomback, MD, MPH Guest: Kelly B. Chen, MSN, AGACNP-BC Guest: Duvuru Geetha, MD On-demand webcast on the latest advances in diagnosing and managing patients with IgA nephropathy (IgAN), including the current data on new and emerging IgAN therapies.

Host: Andrew S. Bomback, MD, MPH Guest: Kelly B. Chen, MSN, AGACNP-BC Guest: Duvuru Geetha, MD On-demand webcast on the latest advances in diagnosing and managing patients with IgA nephropathy (IgAN), including the current data on new and emerging IgAN therapies.

Host: Anne Marie Singh, MD On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.

Host: Emily D. Clark, DO Guest: Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA Guest: Susan Scanland, MSN, CRNP, GNP-BC, CDP Guest: Anthony J. Viera, MD, MPH In this on-demand webcast, leading experts in brain health provide guidance for patient education, discussion, and management geared toward HCPs in primary care who are at the forefront of an aging population at risk of cognitive decline trying to...

Host: Anne Marie Singh, MD On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.

Host: Emily D. Clark, DO Guest: Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA Guest: Susan Scanland, MSN, CRNP, GNP-BC, CDP Guest: Anthony J. Viera, MD, MPH In this on-demand webcast, leading experts in brain health provide guidance for patient education, discussion, and management geared toward HCPs in primary care who are at the forefront of an aging population at risk of cognitive decline trying to...

Host: Praveen Akuthota, MD Guest: Anisha Dua, MD, MPH Guest: Michael E. Wechsler, MD, MMSc On-demand webcast on the latest advances in diagnosing and managing patients with eosinophilic granulomatosis with polyangiitis (EGPA), including current data on new EGPA therapies and shared decision-making strategies to help patients achieve and maintain remission.

Host: Praveen Akuthota, MD Guest: Anisha Dua, MD, MPH Guest: Michael E. Wechsler, MD, MMSc On-demand webcast on the latest advances in diagnosing and managing patients with eosinophilic granulomatosis with polyangiitis (EGPA), including current data on new EGPA therapies and shared decision-making strategies to help patients achieve and maintain remission.

Faculty: Linda Stein Gold, MD Faculty: Bruce Strober, MD, PhD This podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and redefining failure of topical therapies. Clinical features such as high-impact disease sites, failure of topical treatment, or BSA >10% all factor into whether patients are candidates for systemic therapy in this new g...

Faculty: Linda Stein Gold, MD Faculty: Bruce Strober, MD, PhD This podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and redefining failure of topical therapies. Clinical features such as high-impact disease sites, failure of topical treatment, or BSA >10% all factor into whether patients are candidates for systemic therapy in this new g...

Host: Erika Finanger, MD, MS Guest: Aravindhan Veerapandiyan, MD The Duchenne muscular dystrophy (DMD) treatment landscape continues to evolve, with promising therapies emerging from new insights into disease biology. This activity explores the role of aberrant histone deacetylase (HDAC) activity in DMD pathophysiology, including its impact on inflammation, muscle degeneration, adipogenesis, and f...

Host: Erika Finanger, MD, MS Guest: Aravindhan Veerapandiyan, MD The Duchenne muscular dystrophy (DMD) treatment landscape continues to evolve, with promising therapies emerging from new insights into disease biology. This activity explores the role of aberrant histone deacetylase (HDAC) activity in DMD pathophysiology, including its impact on inflammation, muscle degeneration, adipogenesis, and f...

Host: Kelly Chen, MS, LCGC Guest: Chuck Vega, MD, FAAFP Guest: Jay B. Wish, MD On-demand webcast on the pathophysiology of chronic kidney disease (CKD) and expert-informed strategies to help nephrology take the helm in integrating the latest data to provide guideline-concordant care to patients with CKD.

Host: Kelly Chen, MS, LCGC Guest: Chuck Vega, MD, FAAFP Guest: Jay B. Wish, MD On-demand webcast on the pathophysiology of chronic kidney disease (CKD) and expert-informed strategies to help nephrology take the helm in integrating the latest data to provide guideline-concordant care to patients with CKD.